A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques
about
Current efforts and future prospects in the development of live mycobacteria as vaccinesVaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus MacaquesBioorganometallic chemistry with IspG and IspH: structure, function, and inhibition of the [Fe(4)S(4)] proteins involved in isoprenoid biosynthesis.Hippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV).Chemical Mechanism of the Branched-Chain Aminotransferase IlvE from Mycobacterium tuberculosis.Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis.Comparative genomics of the Mycobacterium signaling architecture and implications for a novel live attenuated Tuberculosis vaccine.Modeling tuberculosis in nonhuman primates.Immunology studies in non-human primate models of tuberculosisStable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsRhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment.A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.Development of a new tuberculosis vaccine: is there value in the mucosal approach?Anti-Infectious Human Vaccination in Historical Perspective.Analysis of SecA2-dependent substrates in Mycobacterium marinum identifies protein kinase G (PknG) as a virulence effector.
P2860
Q28087077-68D7F36F-4706-4780-9958-0C77E6C7C641Q28830298-0523C152-EB9A-498A-9479-2CCC4649EBAFQ31149060-0049A8E6-55FD-4CC9-BF74-3654A6C03802Q33607923-E82396FC-5697-44D3-9D03-79ED8089BBB1Q33724359-D5533F6E-FD94-487F-86E6-108E239BB234Q33724924-61A4AFFB-A713-4E8D-B303-EFF84FA3F8FEQ34271541-E73EA909-AC40-4D0E-904D-F9C03666EFFDQ34930509-A41B1E9B-8357-4C40-8A35-47946A41A223Q35116998-38E58B00-4B93-498E-9A55-7FA7BCB1AFAAQ35773904-0F5201A6-702A-4BA5-9360-640A194670D4Q36145561-0F026FB4-9782-48A5-820F-C779C5828541Q36498586-3749B81D-2CBD-4796-816E-44DD6E95CBEFQ37490057-12151898-3AEE-4BAC-A24C-E2362E2413FBQ37563616-D92A8F8D-6769-4A76-9710-C2421463F8AFQ38262258-49F3EF60-97AC-4E44-A556-744D7A8F5C0DQ40129444-5261D68E-6007-4DF7-9858-86D23BDD5FDCQ54403588-7FC77DB2-2018-4460-ABEC-8AAD2EF5C6BF
P2860
A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A recombinant attenuated Mycob ...... virus-infected infant macaques
@ast
A recombinant attenuated Mycob ...... virus-infected infant macaques
@en
type
label
A recombinant attenuated Mycob ...... virus-infected infant macaques
@ast
A recombinant attenuated Mycob ...... virus-infected infant macaques
@en
prefLabel
A recombinant attenuated Mycob ...... virus-infected infant macaques
@ast
A recombinant attenuated Mycob ...... virus-infected infant macaques
@en
P2093
P2860
P921
P356
P1476
A recombinant attenuated Mycob ...... virus-infected infant macaques
@en
P2093
Don R Canfield
Glenn Fennelly
Imran Khan
Kara Jensen
Koen K A Van Rompay
Kristina Abel
Michelle H Larsen
Paul A Luciw
Resmi Ravindran
Uma Devi K Ranganathan
P2860
P304
P356
10.1128/CVI.00184-12
P50
P577
2012-06-13T00:00:00Z